Saksena Seema, Dwivedi Alka, Singla Amika, Gill Ravinder K, Tyagi Sangeeta, Borthakur Alip, Alrefai Waddah A, Ramaswamy Krishnamurthy, Dudeja Pradeep K
Department of Medicine, University of Illinois at Chicago, Jesse Brown VA Medical Center, Chicago, Illinois 60612, USA.
J Cell Biochem. 2008 Oct 1;105(2):454-66. doi: 10.1002/jcb.21842.
SLC26A6 (putative anion transporter 1, PAT1) has been shown to play an important role in mediating the luminal Cl(-)/OH(-)(HCO(3)(-)) exchange process in the intestine. Very little is known about the molecular mechanisms involved in the transcriptional regulation of intestinal SLC26A6 gene expression in the intestine. Current studies were, therefore, designed to clone and characterize the 5'-regulatory region of the human SLC26A6 gene and determine the mechanisms involved in its regulation. A 1,120 bp (p-964/+156) SLC26A6 promoter fragment cloned upstream to the luciferase reporter gene in pGL2-basic exhibited high promoter activity when transfected in Caco2 cells. Progressive deletions of the 5'-flanking region demonstrated that -214/-44 region of the promoter harbors cis-acting elements important for maximal SLC26A6 promoter activity. Since, diarrhea associated with inflammatory bowel diseases is attributed to increased secretion of pro-inflammatory cytokines, we examined the effects of IFNgamma (30 ng/ml, 24 h) on SLC26A6 function, expression and promoter activity. IFNgamma decreased both SLC26A6 mRNA and function and repressed SLC26A6 promoter activity. Deletion analysis indicated that IFNgamma response element is located between -414/-214 region and sequence analysis of this region revealed the presence of potential Interferon Stimulated Responsive Element (ISRE), a binding site (-318/-300 bp) for interferon regulatory factor-1 transcription factor (IRF-1). Mutations in the potential ISRE site abrogated the inhibitory effects of IFNgamma. These studies provided novel evidence for the involvement of IRF-1 in the regulation of SLC26A6 gene expression by IFNgamma in the human intestine.
溶质载体家族26成员6(推定阴离子转运体1,PAT1)已被证明在介导肠道腔内Cl⁻/OH⁻(HCO₃⁻)交换过程中发挥重要作用。关于肠道中SLC26A6基因表达的转录调控所涉及的分子机制,人们了解甚少。因此,当前研究旨在克隆和鉴定人SLC26A6基因的5'调控区,并确定其调控机制。克隆到荧光素酶报告基因pGL2-basic上游的1120 bp(p-964/+156)SLC26A6启动子片段,转染至Caco2细胞时表现出高启动子活性。对5'侧翼区进行逐步缺失分析表明,启动子的-214/-44区域含有对最大SLC26A6启动子活性至关重要的顺式作用元件。由于炎症性肠病相关的腹泻归因于促炎细胞因子分泌增加,我们检测了γ干扰素(30 ng/ml,24小时)对SLC26A6功能、表达和启动子活性的影响。γ干扰素降低了SLC26A6 mRNA水平和功能,并抑制了SLC26A6启动子活性。缺失分析表明,γ干扰素反应元件位于-414/-214区域之间,对该区域的序列分析揭示了潜在的干扰素刺激反应元件(ISRE)的存在,即干扰素调节因子-1转录因子(IRF-1)的结合位点(-318/-300 bp)。潜在ISRE位点的突变消除了γ干扰素的抑制作用。这些研究为IRF-1参与γ干扰素对人肠道中SLC26A6基因表达的调控提供了新证据。